Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

about

Long-Term Results from the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Femoropopliteal Treatment: 3-Year Follow-up.

P2860

Q49835658-990E1658-E732-4F60-B6C3-B89860979F78

P2860

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

Item

http://www.wikidata.org/entity/Q39435685

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

@en

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

@nl

type

Item

label

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

@en

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

@nl

prefLabel

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

@en

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

@nl

P1476

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

@en

P2093

Stefan Müller-Hülsbeck

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.

Collagen and elastin content in canine arteries selected from functionally different vascular beds.

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.

Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems.

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial

A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies.

Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.

4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial.

P31

scholarly article

P356

10.1080/17425247.2016.1230098

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2016-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27580488

http://www.w3.org/2001/XMLSchema#string

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

about

P2860

P2860

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698